why is the fda banning compounded semaglutide moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Is Compounded Semaglutide Safe?
Description
Lilly expects its new drugs, Mounjaro, Zepbound, Ebglyss, Jaypirca, Inluriyo, Kisunla and Omvoh to drive sales growth in 2026

We explain how they differ

Newer to the compounding market since 2022, with less established supply chains

These methods can work, but they are often hard to keep up over time

Whole food sources consistently demonstrate superior effects on satiety and glycemic control compared to processed alternatives with similar macronutrient profiles

It is important to note that there is no official link between GLP-1 medications and actual influenza infection
